Release Date: 24/10/14 08:30 Summary: Q3 Activity Report for the Period Ended 30 September 2014 Price Sensitive: Yes Download Document 288.4KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market